Watermark

BGB-900-102

Completed

Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-900-102

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2022-500694-14

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents